Variation name (cDNA level) | Variation name (protein level) | Variation status | Variation class |
c.3217G>A | p.Glu1073Lys | Heterozygous | Mutation |
wt codon | wt aa | mutant codon | mutant aa | mutational event | mutation type |
GAA | Glu | AAA | Lys | G->A | Ts |
Structure | Key Residue (HCD) | Pyrimidin doublet | CpG |
cb EGF-like #12 | Ca2+ binding | Yes, non coding strand | Yes |
At the mRNA level | On restriction map |
NA | New restriction site(s): none Lost restriction site(s): none |
Conservation (0-1) | SIFT (0-1) | UMD-predictor (0-100) |
---|---|---|
0.83 | 0.00 (pathogenous) | 76 (Pathogenous) |
Sample ID | Patient status | Gender | Transmission | Age of onset | Age of death | Geographic origin |
USA05HOU F0010 I269 | Proband | Female | de novo | at birth | 1 week | U.S.A |
Phenotypic group | Disease |
NA | Neonatal MFS |
Symptom |
C-Aortic insufficiency |
C-Asc. aortic dilatation |
C-Mitral regurgitation |
C-Pulmonary valve insufficiency |
S-Abnormal ears |
S-Arachnodactyly (M) |
S-Characteristic facial appearance |
S-Joint limitations |
Reference ID | PubMed ID | Reference |
26 | 8882780 | Putnam EA, Cho M, Zinn AB, Towbin JA, Byers PH, Milewicz DM. "Delineation of the Marfan phenotype associated with mutations in exons 23-32 of the FBN1 gene". Am J Med Genet 1996 Mar 29;62(3):233-42 . |